[THE EXPERTS CONSENSUS FOR ANTICOAGULANT THERAPY OF VENOUS THROMBOEMBOLISM IN 2016 YR. SIGNIFICANCE OF THE RIVAROXABAN INVESTIGATIONS PROGRAM FOR CHANGES OF APPROACHES, CONCERNING TREATMENT OF THE DEEP VEINS THROMBOSIS AND PULMONARY THROMBOEMBOLISM]
- PMID: 30277356
[THE EXPERTS CONSENSUS FOR ANTICOAGULANT THERAPY OF VENOUS THROMBOEMBOLISM IN 2016 YR. SIGNIFICANCE OF THE RIVAROXABAN INVESTIGATIONS PROGRAM FOR CHANGES OF APPROACHES, CONCERNING TREATMENT OF THE DEEP VEINS THROMBOSIS AND PULMONARY THROMBOEMBOLISM]
Similar articles
-
The Role of New Oral Anticoagulants (NOACs) in Cancer Patients.Adv Exp Med Biol. 2017;906:137-148. doi: 10.1007/5584_2016_112. Adv Exp Med Biol. 2017. PMID: 27620312 Review.
-
The Treatment of Venous Thromboembolism in Patients with Cancer.Adv Exp Med Biol. 2017;906:123-135. doi: 10.1007/5584_2016_111. Adv Exp Med Biol. 2017. PMID: 27620308 Review.
-
[Prevention and treatment of venous thromboembolism in patients with cancer].Dtsch Med Wochenschr. 2012 Oct;137(40):2007-9. doi: 10.1055/s-0032-1305301. Epub 2012 Sep 17. Dtsch Med Wochenschr. 2012. PMID: 22987155 German. No abstract available.
-
АNTICOAGULANT THERAPY IN PATIENTS, SUFFERING IDIOPATHIC DEEP VEINS THROMBOSIS.Klin Khir. 2016 Oct;(10):48-50. Klin Khir. 2016. PMID: 30479114 English, Ukrainian.
-
Vascular Disease Patient Information Page: Cancer-associated thrombosis.Vasc Med. 2020 Jun;25(3):286-288. doi: 10.1177/1358863X20918311. Epub 2020 May 8. Vasc Med. 2020. PMID: 32384252 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical